Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Enanta Pharmaceuticals Inc is a biotechnology business based in the US. Enanta Pharmaceuticals shares (ENTA) are listed on the NASDAQ and all prices are listed in US Dollars. Enanta Pharmaceuticals employs 155 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $58.59 |
|---|---|
| 52-week range | $40.37 - $102.00 |
| 50-day moving average | $76.27 |
| 200-day moving average | $59.70 |
| Wall St. target price | $89.50 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-3.92 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $58.59 from 2022-01-25
| 1 week (2022-01-19) | -0.20% |
|---|---|
| 1 month (2021-12-23) | -23.81% |
| 3 months (2021-10-26) | -22.17% |
| 6 months (2021-07-26) | 41.86% |
| 1 year (2021-01-26) | 19.79% |
|---|---|
| 2 years (2020-01-24) | 6.82% |
| 3 years (2019-01-25) | 82.24 |
| 5 years (2017-01-26) | 75.37% |
Valuing Enanta Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Enanta Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Enanta Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.8 million.
The EBITDA is a measure of a Enanta Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $97.1 million |
|---|---|
| Gross profit TTM | $97.1 million |
| Return on assets TTM | -14.81% |
| Return on equity TTM | -18.48% |
| Profit margin | -81.38% |
| Book value | $19.74 |
| Market capitalisation | $1.1 billion |
TTM: trailing 12 months
We're not expecting Enanta Pharmaceuticals to pay a dividend over the next 12 months.
Over the last 12 months, Enanta Pharmaceuticals's shares have ranged in value from as little as $40.37 up to $102. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Enanta Pharmaceuticals's is 0.5297. This would suggest that Enanta Pharmaceuticals's shares are less volatile than average (for this exchange).
Enanta Pharmaceuticals, Inc. , a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts. .
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.